Evaluation of the mechanism of Action of talimogene laherparepvec (T-VEC) in patients with locally advanced non-melanoma skin cancer.
This study evaluates the administration of T-VEC in non-melanoma skin cancer. The aim is to evaluate the effectiveness, safety and tolerability of T-VEC in patients with non-melanoma skin cancer through determination of local immune effects after repeated T-VEC injections.
| Condition | Basal cell carcinoma, Squamous cell carcinoma, Merkel cell carcinoma, Cutaneous Lymphoma, Non-melanoma Skin Cancer, Non-melanoma Skin Cancer |
|---|---|
| Treatment | Talimogene Laherparepvec (T-VEC) |
| Clinical Study Identifier | NCT03458117 |
| Sponsor | University of Zurich |
| Last Modified on | 22 January 2021 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.